Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0022) — Mineola, New York

Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0022) is a clinical research site located in Mineola, New York, United States 11501.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0022) has participated in 1 clinical trials.

Therapeutic areas: Lung Neoplasms, Non-Small-Cell Lung Carcinoma.

Sponsors: Merck Sharp & Dohme LLC.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0022)?

Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0022) has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0022) conducted?

Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0022) has 1 clinical trials on record. Their work covers Lung Neoplasms, Non-Small-Cell Lung Carcinoma.

Is Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0022) accredited by Crixeo Health?

Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0022) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Perlmutter Cancer Center at NYU Langone Hospital - Long Island ( Site 0022)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.